Home/Filings/4/0001185185-16-005497
4//SEC Filing

U.S. Stem Cell, Inc. 4

Accession 0001185185-16-005497

$USRMCIK 0001388319operating

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 4:06 PM ET

Size

8.2 KB

Accession

0001185185-16-005497

Insider Transaction Report

Form 4
Period: 2016-09-19
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2016-09-19+10,000,00010,341,284 total
    Exercise: $0.02Exp: 2026-09-19Common Stock (10,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2016-09-19+1,500,00011,841,284 total
    Exercise: $0.02From: 2016-09-19Exp: 2026-09-19Common Stock (1,500,000 underlying)
Holdings
  • Common Stock

    9,793
Footnotes (1)
  • [F1]2,500,000 vest on 09/17/2017, 2,500,000 vest on 09/17/2018, 2,500,000 vest on 09/17/2019, and 2,500,000 vest on 09/17/2020.

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001388319

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:06 PM ET
Size
8.2 KB